Multi-Year Breakout Setup with Strong Reward Potential in a Fundamentally Strong Pharma Stock!

The monthly chart is displaying a large symmetrical triangle breakout setup after an extended consolidation phase. Price is now approaching a critical resistance zone around ₹2,100–₹2,150, and a decisive move above this area could unlock a projected upside potential of nearly 60%+ based on the measured pattern target. From an Elliott Wave perspective, the stock appears to have completed a prolonged corrective structure and accumulation phase. The recent strength may indicate the beginning of a fresh Wave-3 impulse, which is typically associated with strong momentum expansion and sustained price trends. The price action also suggests a possible bullish MACD divergence, where momentum improved while the stock was still forming lower or sideways structures during its base-building period. Such divergences often act as early signs of weakening selling pressure before major trend shifts emerge. The stock is also attempting to reclaim its AVWAP zone, which can now become an important support level. Holding above this institutional reference area often reflects renewed buying interest and stronger conviction from larger market participants. The fundamental picture further strengthens the setup: ✔ Strong ROCE and healthy cash generation profile ✔ Consistent profit growth with robust business quality ✔ Global pharmaceutical presence with scalable manufacturing capabilities When long-term chart structure, momentum confirmation, AVWAP strength, and quality fundamentals align, they often create powerful opportunities. A sustained breakout above resistance with strong participation could signal the beginning of a new long-term trend expansion.